IRIS Accounts Production v26.1.0.640 08636528 Board of Directors 1.9.24 31.8.25 31.8.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh086365282024-08-31086365282025-08-31086365282024-09-012025-08-31086365282023-08-31086365282023-09-012024-08-31086365282024-08-3108636528ns15:EnglandWales2024-09-012025-08-3108636528ns14:PoundSterling2024-09-012025-08-3108636528ns10:Director12024-09-012025-08-3108636528ns10:PrivateLimitedCompanyLtd2024-09-012025-08-3108636528ns10:SmallEntities2024-09-012025-08-3108636528ns10:AuditExempt-NoAccountantsReport2024-09-012025-08-3108636528ns10:SmallCompaniesRegimeForDirectorsReport2024-09-012025-08-3108636528ns10:SmallCompaniesRegimeForAccounts2024-09-012025-08-3108636528ns10:FullAccounts2024-09-012025-08-310863652812024-09-012025-08-3108636528ns5:CurrentFinancialInstruments2025-08-3108636528ns5:CurrentFinancialInstruments2024-08-3108636528ns5:ShareCapital2025-08-3108636528ns5:ShareCapital2024-08-3108636528ns5:RetainedEarningsAccumulatedLosses2025-08-3108636528ns5:RetainedEarningsAccumulatedLosses2024-08-3108636528ns10:RegisteredOffice2024-09-012025-08-3108636528ns5:NetGoodwill2024-09-012025-08-3108636528ns5:PlantMachinery2024-09-012025-08-3108636528ns5:FurnitureFittings2024-09-012025-08-3108636528ns5:ComputerEquipment2024-09-012025-08-3108636528ns5:NetGoodwill2024-08-3108636528ns5:NetGoodwill2025-08-3108636528ns5:NetGoodwill2024-08-3108636528ns5:PlantMachinery2024-08-3108636528ns5:FurnitureFittings2024-08-3108636528ns5:ComputerEquipment2024-08-3108636528ns5:PlantMachinery2025-08-3108636528ns5:FurnitureFittings2025-08-3108636528ns5:ComputerEquipment2025-08-3108636528ns5:PlantMachinery2024-08-3108636528ns5:FurnitureFittings2024-08-3108636528ns5:ComputerEquipment2024-08-3108636528ns5:WithinOneYearns5:CurrentFinancialInstruments2025-08-3108636528ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3108636528ns5:WithinOneYear2025-08-3108636528ns5:WithinOneYear2024-08-3108636528ns5:BetweenOneFiveYears2025-08-3108636528ns5:BetweenOneFiveYears2024-08-3108636528ns5:AllPeriods2025-08-3108636528ns5:AllPeriods2024-08-3108636528ns10:Director112024-08-3108636528ns10:Director112023-08-3108636528ns10:Director112024-09-012025-08-3108636528ns10:Director112023-09-012024-08-3108636528ns10:Director112025-08-3108636528ns10:Director112024-08-3108636528ns10:Director32024-09-012025-08-3108636528ns10:Director332024-08-3108636528ns10:Director332023-08-3108636528ns10:Director332024-09-012025-08-3108636528ns10:Director332023-09-012024-08-3108636528ns10:Director332025-08-3108636528ns10:Director332024-08-31
REGISTERED NUMBER: 08636528 (England and Wales)














Unaudited Financial Statements

for the Year Ended 31 August 2025

for

Conran Late Night Pharma Limited

Conran Late Night Pharma Limited (Registered number: 08636528)






Contents of the Financial Statements
for the Year Ended 31 August 2025




Page

Balance Sheet 1

Notes to the Financial Statements 2


Conran Late Night Pharma Limited (Registered number: 08636528)

Balance Sheet
31 August 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 3,239 3,535
3,239 3,535

CURRENT ASSETS
Stocks 37,686 35,203
Debtors 6 123,568 171,479
Cash at bank and in hand 60,047 47,495
221,301 254,177
CREDITORS
Amounts falling due within one year 7 197,688 192,967
NET CURRENT ASSETS 23,613 61,210
TOTAL ASSETS LESS CURRENT LIABILITIES 26,852 64,745

PROVISIONS FOR LIABILITIES 810 884
NET ASSETS 26,042 63,861

CAPITAL AND RESERVES
Called up share capital 10 10
Retained earnings 26,032 63,851
SHAREHOLDERS' FUNDS 26,042 63,861

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 May 2026 and were signed on its behalf by:





Mr H F Chaudry - Director


Conran Late Night Pharma Limited (Registered number: 08636528)

Notes to the Financial Statements
for the Year Ended 31 August 2025

1. STATUTORY INFORMATION

Conran Late Night Pharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 08636528

Registered office: Spring Court
Spring Road
Hale
Altrincham
Cheshire
WA14 2UQ

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity and the costs incurred or to be incurred in respect of the transactions can be measured reliable.

Goodwill
Goodwill, being the amount paid in connection with the aquisition of a business in 2013, has been amortised in full over its useful economic life.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Conran Late Night Pharma Limited (Registered number: 08636528)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2024 - 9 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 September 2024
and 31 August 2025 35,000
AMORTISATION
At 1 September 2024
and 31 August 2025 35,000
NET BOOK VALUE
At 31 August 2025 -
At 31 August 2024 -

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 September 2024 975 18,646 4,346 23,967
Additions - - 1,123 1,123
At 31 August 2025 975 18,646 5,469 25,090
DEPRECIATION
At 1 September 2024 589 17,060 2,783 20,432
Charge for year 96 396 927 1,419
At 31 August 2025 685 17,456 3,710 21,851
NET BOOK VALUE
At 31 August 2025 290 1,190 1,759 3,239
At 31 August 2024 386 1,586 1,563 3,535

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Other debtors 123,568 171,479

Conran Late Night Pharma Limited (Registered number: 08636528)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 158,076 167,003
Taxation and social security 1,934 3,893
Other creditors 37,678 22,071
197,688 192,967

8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2025 2024
£    £   
Within one year 2,746 6,590
Between one and five years - 2,197
2,746 8,787

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 August 2025 and 31 August 2024:

2025 2024
£    £   
Mr H F Chaudry
Balance outstanding at start of year 66,994 87,789
Amounts advanced 26,513 3,261
Amounts repaid (62,304 ) (24,056 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 31,203 66,994

Dr K M Syed
Balance outstanding at start of year 260 260
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 260 260